For media enquiries, please contact

Rob Clancy
Communications and Media Manager
m: + 61 3 8572 2761
e: communications@hudson.org.au

---

Media 2022

September

Fertility Guide | Busting the myths
West Australian

Happy to bring life’s work home
Dr Stacey Ellery
The Australian

Taming the Enemy Within
Bio spectrum

August

Is it time for men to take responsibility for contraception?
Professor Robert McLachlan
Body+Soul
Sunday Tasmania

Study identifies immune regulator as critical contributor to stomach cancer development
Professor Brendan Jenkins and Dr Ruby Dawson
MedicalXpress

July

What makes Invion (ASX:IVX) well placed to tap opportunities in the biotech space
Dr Andrew Stephens
Kalkine Media

June

Aussie scientists determined to prevent brain injury in babies
Professor Suzanne Miller, PhD student Madeleine Smith, Dr Tayla Penny and Dr Courtney McDonald
Big News Network
WN.com
Lupitan 6, Jackarta

The COVID-flu nexus: how is having COVID around changing our flu season?
Associate Professor Michelle Tate
Cosmos Magazine
Hornsby Post

Australian HR Awards 2022: Excellence Awardees revealed
Human Resources Director

$1.45 million grant to fund inflammation research
Proactive Investors
BioSpectrum

Philanthropy accelerates stroke trials
TV | 9News
The National Tribune

Finish line for ACT-Melbourne cancer ride
Dr Simon Chu
TV | 7news
Radio | 3AW
Radio | ABC Canberra
7NEWS
Canberra Weekly

IVF sons don’t inherit dad’s fertility issues
Herald Sun

Stem Cells Grown in 3D Conditions May Lose Anti-scarring Properties
Associate Professor Rebecca Lim
Pulmonary Fibrosis News

Noxopharm collaborator Hudson Institute secures $100,000 Victorian grant to study RNA-based therapeutics
Associate Professor Michael Gantier
Proactive Investors

Antimicrobial Resistance
Dr Jacqueline Pearson
Radio | 3RRR

Invion (ASX:IVX) confirms significant effectiveness improvement when ICI used with INV043 drug
Dr Andrew Stephens
The Market Herald

May

Researchers Discover New Enzyme For Better Treatment Of Cancers And Inflammatory Conditions
RTT News

The 70 employers now certified as being a Family Inclusive Workplace
Women’s agenda
Smart Company

How far has Invion’s (ASX:IVX) cancer treatment progressed?
Kalkine Media

Inner Wheel walks for good cause
Professor Suzanne Miller
Berwick Star News

New hope for Australians suffering from drug resistant high blood pressure
Dr Jun Yang
TV | 7NEWS
Medicine Today

Lupus gene discovery could lead to more effective treatments
Associate Professor Michael Gantier
Hospital and Healthcare
Freethink
VNexplorer

Ride for ovarian cancer
Dr Simon Chu
TV | Win news
Radio | 3AW
Radio | ABC Gold Coast
Canberra Weekly
Wangaratta Chronical

How antimicrobial resistance spreads inside the human gut
Dr Samuel Forster
Australian Hospital and Healthcare Bulletin

April

Discovery may ease the agony of lupus
Associate Professor Michael Gantier
The Australian
Radio | 4BC
Radio | 2GB
Radio | ABC Wimmera
Labonline

Walk to aid
Professor Suzanne Miller
Pakenham News

Meet Invion’s (ASX:IVX) leadership team guiding its clinical journey in cancer treatment
Rob Merriel
Kalkine Media

New bacteria associated with inflammatory bowel disease discovered in mice
Dr Samuel Forster
Medical Xpress
Cambridge Network
Pharmiweb

Ride for research into Ovarian cancer
Dr Simon Chu
Tumut and Adelong Times

Hormone imbalance may explain your high blood pressure
Dr Jun Yang
Australian Health Information Technology

Capturing Live Cells with Counterflow Technology via Dead Cell Removal
Associate Professor Rebecca Lim
Genetic Engineering & Biotechnology News

March

Hormone imbalance may explain your high blood pressure | study
Dr Jun Yang, Dr Renata Libianto
Australian Financial Review
Radio | ABC, Health Report with Dr Norman Swan
The Medical Journal of Australia
LabOnline

Here’s what you need to know about Invion’s (ASX:IVX) world-leading partners in its mission to treat cancers
Kalkine Media

Uncovering the mechanism driving a global health threat | antimicrobial resistance
Dr Sam Forster
Radio | ABC News
Radio | ABC Sydney
Radio | ABC Melbourne
Lab+Life Scientist
Hospital and Healthcare
Scimex

Adiso ‘sprints out of the gate’ with inflammatory disease focused pipeline that includes LBPs
BioPharma

Here is why Invion’s (ASX:IVX) clinical journey to cancer treatment deserves attention
Kalkine media

Neve was diagnosed with a rare ovarian cancer at just 11-months-old
Dr Simon Chu
9Honey | Parenting

Researchers seek juvenile cancer cause
Dr Simon Chu
Herald Sun
Geelong Advertiser

February

Shining light on juvenile ovarian cancer
Dr Simon Chu
Retail Pharmacy

The silent killer: Why medical research is fired up about inflammation
Professor Elizabeth Hartland, Associate Professor Michael Gantier, Dr Sam Forster
The Age
Sydney Morning Herald
Radio | ABC Radio Sydney

Fifty per cent of deaths worldwide have one thing in common …
Professor Elizabeth Hartland
Sydney Morning Herald
Podcast | Good Weekend Talks

Hopes for Photosoft technology development as it prepares for clinical trials
Kalkine Media

Funds help studies in ovarian cancer fight
Professor Ron Firestein
Herald Sun
Courier Mail
Geelong Advertiser
The National Tribune
Retail Pharmacy

Victorian research consortium to fight childhood cancer
Professor Ron Firestein
Health Dispatch
Biotech Dispatch
Australian Government Department of Health
Greg Hunt

Cancer crusaders to share in $9.6m grant
Herald Sun

January

Microbiome medicine accelerated by new partnership between BiomeBank and Hudson Institute
Professor Elizabeth Hartland, Dr Sam Forster
Yahoo Finance
Bio Space
Business Wire
Drug Discovery World

Researchers discover way to disarm potentially deadly Listeria bacteria
UQ News
Food safety news

Invion: Activities Report and Appendix 4C
Market Screener